Very Early Biologic Therapy within Six Months of Crohn’s Disease Diagnosis Improves One-Year Steroid-Free Clinical Remission: A Retrospective Cohort Study

Digestion 2026

View at publisher
Authors: Yen-Cheng Chang, Shih-Hua Lin, Tai‐Di Chen, Chia-Jung Kuo, Chien-Ming Chen, Chen‐Wang Chang, Jen‐Wei Chou, Cheng‐Tang Chiu, Ming‐Yao Su, Yu-Bin Pan, Puo‐Hsien Le
DOI: 10.1159/000550394
Cited by: 0
References: 26

Abstract

INTRODUCTION: Early use of biologics improves outcomes for Crohn's disease (CD). Evidence now indicates that initiating therapy within 6 months of diagnosis - the "very early" window - may yield additional benefits over the traditional ≤2-year target. We therefore compared 1-year outcomes after very early (

Fields of Study & Subjects

Inflammatory Bowel Disease Ocular Diseases and Behçet’s Syndrome Pregnancy and Medication Impact

Publication details

Journal / source
Digestion
Pages
1–10
Publication date
9 January 2026
Language
EN